BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan in Patients with Limb-girdle Muscular Dystrophy Type 2I Marketscreener.com
Recommendation and review posted by G. Smith
Search Immortality Topics: |
Posted: March 23, 2023 at 12:24 am
BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan in Patients with Limb-girdle Muscular Dystrophy Type 2I Marketscreener.com
Recommendation and review posted by G. Smith